3{40 ,4{40 -Dihydroxy-2-(isopropylamino)acetophenone intraocular pressure lowering process

摘要

Topical administration of 3',4'-dihydroxy-2-(isopropylamino)acetophenone to the mammalian eye reduces intraocular pressure without side effects generally associated with adrenergic activation such as tachycardia, mydriasis, hypertension and hypotension.